June 13, 2012 — M*Modal Inc. announced the M*Modal Catalyst family of cloud-based applications, enabling healthcare decision-makers to extract actionable information from “unstructured” medical documentation, regardless of how that data was created, and combine it with structured data contained in electronic clinical systems.

Best Cyclotron Systems is unveiling five new cyclotrons for isotope research and production at the Society of Nuclear Medicine (SNM) 2012 Annual Meeting on June 9-12 in Miami Beach, Fla.

Novarad’s NovaDose solution that calculates cumulative patient, exam and modality ionizing radiation dose history now automatically reports the patient’s exam dose profile from directly into the NovaRIS diagnostic report without dictation or manual entry. This new convenience increases ease of use and saves time.

June 11, 2012 — Mevion Medical Systems, Inc., a radiation therapy company dedicated to advancing the treatment of cancer, announced that it has received FDA 510(k) clearance for its Mevion S250 Proton Therapy System. The Mevion S250 is a first-of-its-kind proton therapy system that provides the same precise, non-invasive treatment advantages and capabilities of complex, large, and costly proton therapy systems but with higher patient throughput, a significantly reduced footprint, improved reliability, and lower implementation and operational costs.  The Mevion S250 delivers precise and intense proton beams that physicians can use to treat tumors and lesions or any other condition where radiotherapy is indicated.